Abstract
Interferon-γ is a key cytokine in tumor immunosurveillance. The recently described interferon-producing killer dendritic cell (IKDC), can be distinguished from other innate effectors by its ability to kill a large variety of tumor cells and to produce high amounts of interferon-γ after encountering tumors in the absence of exogenous cytokines. The cytotoxic activity of IKDC was unraveled during an efficient immunotherapy combining c-kit tyrosine kinase inhibitors and interleukin-2, and is mediated through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and interferon type IIR.
Original language | English |
---|---|
Pages (from-to) | 872-877 |
Number of pages | 6 |
Journal | Biochimie |
Volume | 89 |
Issue number | 6-7 |
DOIs | |
Publication status | Published - 1 Jun 2007 |
Keywords
- Dendritic cells
- Imatinib mesylate
- Interferon-producing killer dendritic cells
- Interferon-γ
- Interleukin-2
- TNF-related apoptosis-inducing ligand
- Tumor immunity
- c-kit tyrosine kinase inhibitor